Thomas Dick

65PUBLICATIONS
60CO-AUTHORS
Medical mycologyPharmacogenomicsBiologically active moleculesMedical infection agents (incl. prions)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Oct 01, 2026
Falling short: Inadequate target attainment in guideline-based therapy of nontuberculous mycobacterial disease.

|Jun 23, 2026
Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction.

|Jun 02, 2026
Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine Amides.

|Jan 28, 2026
Loss-of-Function Mutations in the Penicillin-Binding Protein PonA1 Confer Agar-Dependent Resistance to Durlobactam in Mycobacterium abscessus.

Dereje Abate Negatu, Wassihun Wedajo Aragaw, Min Xie

|May 01, 2025
Next-generation rifamycins for the treatment of mycobacterial infections.

Véronique Dartois, Tian Lan, Uday S Ganapathy

|Apr 01, 2025
Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease.

Jickky Palmae Sarathy, Min Xie, Chui Fann Wong

Pageof 11

Frequent Collaborators

28 joint publications

Véronique Dartois

15 joint publications

Martin Gengenbacher

5 joint publications

Gerhard Grüber

4 joint publications

Wassihun Wedajo Aragaw